1-4 of 4
Zhengqi Wang, Ph.D.
Close
Sort by
Journal Articles

Genetic and Pharmacologic Targeting of STAT5/Gab2/PI3K/mTOR Signaling in a Mouse Myeloproliferative Disease Model.

Geqiang Li, Ph.D., Zhengqi Wang, Ph.D., Kristy L. Miskimen, Ph.D., Xiu Yan Xie, M.D., William Tse, M.D., Fabrice Gouilleux, Ph.D., Richard Moriggl, Ph.D., Kevin D. Bunting, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 3902.
https://doi.org/10.1182/blood.V114.22.3902.3902
Published: 2009
Journal Articles

Regulation of Hematopoietic Stem Cell Quiescence by Ku70.

Yulan Qing, PhD, Zhengqi Wang, Ph.D., Min Liu, Kevin D. Bunting, PhD, Stanton L. Gerson, MD
Journal: Blood
Blood (2009) 114 (22): 3613.
https://doi.org/10.1182/blood.V114.22.3613.3613
Published: 2009
Journal Articles

STAT5 Requires the N-Domain for Suppression of miR15/16, Induction of Bcl-2, and Survival Signaling in Myeloproliferative Disease.

Geqiang Li, Ph.D., Kristy L. Miskimen, Ph.D., Zhengqi Wang, Ph.D., Xiu Yan Xie, M.D., Jennifer Brenzovich, B.S., John J Ryan, Ph.D., William Tse, M.D., Richard Moriggl, Ph.D., Kevin D. Bunting, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 211.
https://doi.org/10.1182/blood.V114.22.211.211
Published: 2009
Journal Articles

Physiologically Significant Genetic Interaction between STAT5 and Gab2 during Normal and Pathologic Hematopoiesis.

Geqiang Li, PhD, Zhengqi Wang, Ph.D., Yi Zhang, Ph.D., Eleonora Haviernikova, M.S., William Tse, M.D., Kevin D. Bunting, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 87.
https://doi.org/10.1182/blood.V110.11.87.87
Published: 2007